These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 476126)

  • 21. A structural model to explain the partial catalytic activity of human prorenin.
    Heinrikson RL; Hui J; Zürcher-Neely H; Poorman RA
    Am J Hypertens; 1989 May; 2(5 Pt 1):367-80. PubMed ID: 2655662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and quantification of renin and prorenin in the bovine eye.
    Deinum J; Derkx FH; Danser AH; Schalekamp MA
    Endocrinology; 1990 Mar; 126(3):1673-82. PubMed ID: 2407520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of intrinsic inhibitors in acid-activation of inactive plasma renin (prorenin).
    Derkx FH; Schalekamp MP; Schalekamp MA
    Clin Exp Hypertens A; 1982; 4(11-12):2123-31. PubMed ID: 6756686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and isolation of inactive, large molecular weight renin in human kidney and plasma.
    Atlas SA; Sealey JE; Dharmgrongartama B; Hesson TE; Laragh JH
    Hypertension; 1981; 3(3 Pt 2):I30-40. PubMed ID: 7021414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin can activate plasma prorenin but is not required for the alkaline phase of acid activation.
    Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():97s-99s. PubMed ID: 44236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site.
    Sealey JE; Catanzaro DF; Lavin TN; Gahnem F; Pitarresi T; Hu LF; Laragh JH
    Am J Hypertens; 1996 May; 9(5):491-502. PubMed ID: 8735181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of plasma and amniotic prorenin by metalloprotease and trypsin.
    Takada Y; Brown SW; Erdös EG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):569-76. PubMed ID: 3511083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary gland tissue kallikrein family and processing of growth factor precursors and proenzymes.
    Hosoi K; Kurabuchi S; Kikkawa Y; Tada J; Akamatsu T; Yamanaka N; Matsumoto T; Kanamori N; Tsumura K
    Eur J Morphol; 1998 Aug; 36 Suppl():82-5. PubMed ID: 9825898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of kallikrein, plasmin, and thrombin on hog kidney renin.
    Overturf ML; Druihet RE; Fitz A
    J Biol Chem; 1979 Dec; 254(23):12078-83. PubMed ID: 159304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity between physicochemical properties of recombinant rat prorenin and native inactive renin.
    Hosoi M; Kim S; Yamauchi T; Watanabe T; Murakami K; Suzuki F; Takahashi A; Nakamura Y; Yamamoto K
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):727-31. PubMed ID: 2039449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of acid-activation of renin: role of kallikrein in renin activation.
    Hsueh WA; Carlson EJ; Israel-Hagman M
    Hypertension; 1981; 3(3 Pt 2):I22-9. PubMed ID: 7021413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an enzyme in human kidney that correctly processes prorenin.
    Shinagawa T; Do YS; Baxter JD; Carilli C; Schilling J; Hsueh WA
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1927-31. PubMed ID: 2408045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma kallikrein and plasmin as activators of prorenin: links between the renin-angiotensin system and other proteolytic systems in plasma.
    Schalekamp MA; Derkx FH
    Clin Sci (Lond); 1981 Jul; 61(1):15-21. PubMed ID: 6454526
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody.
    Derkx FH; Deinum J; Lipovski M; Verhaar M; Fischli W; Schalekamp MA
    J Biol Chem; 1992 Nov; 267(32):22837-42. PubMed ID: 1429632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.
    Wilczynski EA; Osmond DH
    Hypertension; 1983; 5(3):277-85. PubMed ID: 6341216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prorenin and other large molecular weight forms of renin.
    Sealey JE; Atlas SA; Laragh JH
    Endocr Rev; 1980; 1(4):365-91. PubMed ID: 6788544
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and immunological differences between plasma inactive renin from normal and nephrectomized rats.
    Kim S; Hosoi M; Nakajima K; Yamamoto K
    Can J Physiol Pharmacol; 1991 Sep; 69(9):1350-4. PubMed ID: 1756436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the presence of differently glycosylated forms of prorenin in the plasma of anephric man.
    Hosoi M; Kim S; Tabata T; Nishitani H; Nishizawa Y; Morii H; Murakami K; Yamamoto K
    J Clin Endocrinol Metab; 1992 Mar; 74(3):680-4. PubMed ID: 1740505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency.
    Patrassi GM; Mantero F; Fallo F; Girolami A; Derkx FH
    Res Exp Med (Berl); 1985; 185(3):217-20. PubMed ID: 3895336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.